Medicine & Pharmaceuticals

- ABC6 Sports Team

Latest News Releases

*DISCLAIMER*: Information contained on this page is provided by companies via press release distributed through PR Newswire, an independent third-party content provider. PR Newswire, Frankly and this Station make no warranties or representations in connection therewith.

HeadlinesMore>>
Concordia International Corp. Announces Amendments to its CBCA Plan of Arrangement in Connection with its Recapitalization Transaction
Concordia International Corp. Announces Amendments to its CBCA Plan of Arrangement in Connection with its Recapitalization Transaction
OAKVILLE, ON, June 18, 2018 /PRNewswire/ - Concordia International Corp. ("Concordia" or the "Company") (TSX: CXR) announced today that, in connection with the previously announced proposed recapitalization transaction...More >>
OAKVILLE, ON, June 18, 2018 /PRNewswire/ - Concordia International Corp. ("Concordia" or the "Company") (TSX: CXR) announced today that, in connection with the previously announced proposed recapitalization transaction...More >>
FDA Approves the Next Generation of Customized LASIK Treatment with iDESIGN Refractive Studio
FDA Approves the Next Generation of Customized LASIK Treatment with iDESIGN Refractive Studio
Johnson & Johnson Vision announced today the U.S. Food and Drug Administration (FDA) approval of the iDESIGN Refractive Studio, making it the only system to use topography-integrated, wavefront-guided technology.2 This...More >>
Johnson & Johnson Vision announced today the U.S. Food and Drug Administration (FDA) approval of the iDESIGN Refractive Studio, making it the only system to use topography-integrated, wavefront-guided technology.2 This...More >>
Leviticus Cardio Announces Successful Animal Trial Demonstrating Wireless Power to Jarvik 2000
Leviticus Cardio Announces Successful Animal Trial Demonstrating Wireless Power to Jarvik 2000
Leviticus Cardio, inventor of wireless technology for certain medical devices, announces the successful animal implantation of the world's first Hybrid Wireless Fully Implanted Ventricular Assisted System or "Hybrid...More >>
Leviticus Cardio, inventor of wireless technology for certain medical devices, announces the successful animal implantation of the world's first Hybrid Wireless Fully Implanted Ventricular Assisted System or "Hybrid...More >>
EFIC: Fresh Ideas in Pain Research
EFIC: Fresh Ideas in Pain Research
Creative approaches to research by young scientists provide opportunity for new and challenging thinking to benefit patients who suffer from pain.To move such approaches from a conceptual framework to a research project,...More >>
Creative approaches to research by young scientists provide opportunity for new and challenging thinking to benefit patients who suffer from pain.To move such approaches from a conceptual framework to a research project,...More >>
National Advisory Committee on Immunization (NACI) recommends SHINGRIX for the prevention of shingles for adults aged 50 and up
National Advisory Committee on Immunization (NACI) recommends SHINGRIX for the prevention of shingles for adults aged 50 and up
MISSISSAUGA, ON, June 18, 2018 /CNW/ - The National Advisory Committee on Immunization (NACI) has made a strong recommendation for SHINGRIX, GSK's vaccine for the prevention of shingles. NACI recommends SHINGRIX should...More >>
MISSISSAUGA, ON, June 18, 2018 /CNW/ - The National Advisory Committee on Immunization (NACI) has made a strong recommendation for SHINGRIX, GSK's vaccine for the prevention of shingles. NACI recommends SHINGRIX should...More >>
Thermo Fisher Scientific Launches Ion AmpliSeq HD Technology
Thermo Fisher Scientific Launches Ion AmpliSeq HD Technology
Thermo Fisher Scientific today announced the launch of its Ion AmpliSeq HD technology, the latest next-generation library preparation innovation that, for the first time, provides clinical researchers with the flexibility...More >>
Thermo Fisher Scientific today announced the launch of its Ion AmpliSeq HD technology, the latest next-generation library preparation innovation that, for the first time, provides clinical researchers with the flexibility...More >>
GammaDelta Therapeutics Appoints Michael Koslowski as CMO
GammaDelta Therapeutics Appoints Michael Koslowski as CMO
GammaDelta Therapeutics Ltd, an emerging biotech company developing novel immunotherapies for cancer and other diseases announced today that it has strengthened its leadership team with the appointment of Michael...More >>
GammaDelta Therapeutics Ltd, an emerging biotech company developing novel immunotherapies for cancer and other diseases announced today that it has strengthened its leadership team with the appointment of Michael...More >>
A diabetes diagnosis later in life may signal early pancreatic cancer in African Americans and Latinos
A diabetes diagnosis later in life may signal early pancreatic cancer in African Americans and Latinos
Each year, more than one million Americans are diagnosed with adult-onset diabetes mellitus, also known as type 2 diabetes. The new diagnosis comes with a long list of potential complications: high blood pressure, nerve...More >>
Each year, more than one million Americans are diagnosed with adult-onset diabetes mellitus, also known as type 2 diabetes. The new diagnosis comes with a long list of potential complications: high blood pressure, nerve...More >>
Aprea Therapeutics Presents Results From Phase Ib/II Clinical Study of APR-246 and Azacitidine (AZA) in Patients with TP53 Mutant Myelodysplastic Syndromes (MDS) at the 2018 European Hematology Association (EHA) Annual Meeting in Stockholm
Aprea Therapeutics Presents Results From Phase Ib/II Clinical Study of APR-246 and Azacitidine (AZA) in Patients with TP53 Mutant Myelodysplastic Syndromes (MDS) at the 2018 European Hematology Association (EHA) Annual Meeting in Stockholm
Aprea Therapeutics today presented results at the 2018 AACR Annual Meeting from its ongoing Phase Ib/II clinical study in MDS. The ongoing study, sponsored by the Moffitt Cancer Center with financial support from the Evans...More >>
Aprea Therapeutics presented results at the 2018 EHA Annual Meeting from its Phase Ib/II clinical study in MDS. The ongoing study is evaluating the safety and efficacy of APR-246 in combination with azacitidine for the...More >>
Updated Preliminary Data from SMA FIREFISH Program in Type 1 Babies Presented at the CureSMA Conference
Updated Preliminary Data from SMA FIREFISH Program in Type 1 Babies Presented at the CureSMA Conference
PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced the presentation of updated interim clinical data from Part 1 of the FIREFISH study investigating risdiplam (RG7916) in babies with Type 1 Spinal Muscular Atrophy...More >>
PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced the presentation of updated interim clinical data from Part 1 of the FIREFISH study investigating risdiplam (RG7916) in babies with Type 1 Spinal Muscular Atrophy...More >>
Phase 3 QuANTUM-R Study Demonstrates Daiichi Sankyo's Quizartinib Significantly Prolongs Overall Survival as Single Agent Compared to Chemotherapy in Patients with Relapsed/Refractory AML with FLT3-ITD Mutations
Phase 3 QuANTUM-R Study Demonstrates Daiichi Sankyo's Quizartinib Significantly Prolongs Overall Survival as Single Agent Compared to Chemotherapy in Patients with Relapsed/Refractory AML with FLT3-ITD Mutations
Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) announced that positive results from the pivotal QuANTUM-R phase 3 study of single agent quizartinib were presented today as a late-breaking oral presentation in...More >>
Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) announced that positive results from the pivotal QuANTUM-R phase 3 study of single agent quizartinib were presented today as a late-breaking oral presentation in...More >>
Novartis JULIET trial of Kymriah demonstrates more than one-year durability of responses in adults with relapsed or refractory DLBCL
Novartis JULIET trial of Kymriah demonstrates more than one-year durability of responses in adults with relapsed or refractory DLBCL
Novartis today announced 14-month results from the pivotal JULIET clinical trial showing ongoing durable responses are achievable with Kymriah® (tisagenlecleucel) when administered to adult patients with relapsed or...More >>
Novartis today announced 14-month results from the pivotal JULIET clinical trial showing ongoing durable responses are achievable with Kymriah® (tisagenlecleucel) when administered to adult patients with relapsed or...More >>
European Hematology Association: iNNOVATE Study: Ibrutinib Plus Rituximab for Patients With Waldenström's Macroglobulinemia
European Hematology Association: iNNOVATE Study: Ibrutinib Plus Rituximab for Patients With Waldenström's Macroglobulinemia
Waldenström's Macroglobulinemia (WM) is a rare type of blood cancer. Since WM is rare, it is difficult to conduct large clinical studies and determine a standard treatment for the disease. Rituximab, a therapy used to...More >>
Waldenström's Macroglobulinemia (WM) is a rare type of blood cancer. Since WM is rare, it is difficult to conduct large clinical studies and determine a standard treatment for the disease. Rituximab, a therapy used to...More >>
Indivior Is Granted Temporary Restraining Order
Indivior Is Granted Temporary Restraining Order
Indivior PLC (LON: INDV) ("Indivior" or the "Company") today announced that the U.S. District Court for the District of New Jersey has granted Indivior a temporary restraining order (TRO) that compels Dr. Reddy's (DRL)...More >>
Indivior PLC (LON: INDV) ("Indivior" or the "Company") today announced that the U.S. District Court for the District of New Jersey has granted Indivior a temporary restraining order (TRO) that compels Dr. Reddy's (DRL)...More >>
Global Medication Pouch Inspection System Market Analysis & Trends 2018-2027 by Machine Type, Operating Speed, End-User & Geography
Global Medication Pouch Inspection System Market Analysis & Trends 2018-2027 by Machine Type, Operating Speed, End-User & Geography
The "Global Medication Pouch Inspection System Market Analysis & Trends - Industry Forecast to 2027" report has been added to ResearchAndMarkets.com's offering. The Global Medication Pouch Inspection Systems...More >>
The "Global Medication Pouch Inspection System Market Analysis & Trends - Industry Forecast to 2027" report has been added to ResearchAndMarkets.com's offering. The Global Medication Pouch Inspection Systems...More >>
Pri-Med Launches Complete Online Coverage of Live Events
Pri-Med Launches Complete Online Coverage of Live Events
Pri-Med, a leading provider of continuing medical education for primary care providers, has begun to make its Annual Conference CME sessions available in nearly real time. Taking a cue from popular consumer sites that make...More >>
Pri-Med, a leading provider of continuing medical education for primary care providers, has begun to make its Annual Conference CME sessions available in nearly real time. Taking a cue from popular consumer sites that make...More >>
Global Sodium Acetate Market 2018-2022: Growing Prominence in Medical and Pharmaceutical Sectors
Global Sodium Acetate Market 2018-2022: Growing Prominence in Medical and Pharmaceutical Sectors
The "Global Sodium Acetate Market 2018-2022" report has been added to ResearchAndMarkets.com's offering. The global sodium acetate market to grow at a CAGR of 7.19% during the period 2018-2022. Global Sodium...More >>
The "Global Sodium Acetate Market 2018-2022" report has been added to ResearchAndMarkets.com's offering. The global sodium acetate market to grow at a CAGR of 7.19% during the period 2018-2022. Global Sodium...More >>
Gene Therapy for Mucopolysaccharidosis Pipeline Analysis Report 2018 Featuring Sangamo Therapeutics, Swedish Orphan Biovitrum & uniQure
Gene Therapy for Mucopolysaccharidosis Pipeline Analysis Report 2018 Featuring Sangamo Therapeutics, Swedish Orphan Biovitrum & uniQure
The "Gene Therapy for Mucopolysaccharidosis - A Pipeline Analysis Report" report has been added to ResearchAndMarkets.com's offering. This pipeline analysis report provides detailed insights into the clinical trials...More >>
The "Gene Therapy for Mucopolysaccharidosis - A Pipeline Analysis Report" report has been added to ResearchAndMarkets.com's offering. This pipeline analysis report provides detailed insights into the clinical trials...More >>
Gene Therapy for Age-related Macular Degeneration Pipeline Analysis Report 2018 Featuring RetroSense Therapeutics, REGENXBIO & AGTC
Gene Therapy for Age-related Macular Degeneration Pipeline Analysis Report 2018 Featuring RetroSense Therapeutics, REGENXBIO & AGTC
The "Gene Therapy for Age-related Macular Degeneration - A Pipeline Analysis Report" report has been added to ResearchAndMarkets.com's offering. This pipeline analysis report provides detailed insights into the...More >>
The "Gene Therapy for Age-related Macular Degeneration - A Pipeline Analysis Report" report has been added to ResearchAndMarkets.com's offering. This pipeline analysis report provides detailed insights into the...More >>
Indivior Responds to Generic SUBOXONE® Approvals and Dr. Reddy's Launch "At-Risk"
Indivior Responds to Generic SUBOXONE® Approvals and Dr. Reddy's Launch "At-Risk"
Indivior PLC (LON: INDV) ("Indivior" or the "Company") today announced that it is aware that, on 14 June 2018, the US FDA approved generic versions of SUBOXONE® Film from both Dr. Reddy's and Mylan, and that Dr....More >>
Indivior PLC (LON: INDV) ("Indivior" or the "Company") today announced that it is aware that, on 14 June 2018, the US FDA approved generic versions of SUBOXONE® Film from both Dr. Reddy's and Mylan, and that Dr....More >>
Global Angiography Equipment Market, 2023 - Growing Demand for Interventional Angiography Systems in Minimally Invasive Surgeries
Global Angiography Equipment Market, 2023 - Growing Demand for Interventional Angiography Systems in Minimally Invasive Surgeries
The "Angiography Equipment Market by Product (Angiography Systems, Catheters, Guidewire, Balloons, Contrast Media), Technology (X-Ray, CT, MRA), Procedure (Coronary, Endo, Neuro), Application & Patient Care Setting -...More >>
The "Angiography Equipment Market by Product (Angiography Systems, Catheters, Guidewire, Balloons, Contrast Media), Technology (X-Ray, CT, MRA), Procedure (Coronary, Endo, Neuro), Application & Patient Care Setting -...More >>
Blueprint Medicines Announces Updated Data from Ongoing Phase 1 EXPLORER Clinical Trial of Avapritinib in Patients with Advanced Systemic Mastocytosis Showing Profound and Durable Clinical Activity
Blueprint Medicines Announces Updated Data from Ongoing Phase 1 EXPLORER Clinical Trial of Avapritinib in Patients with Advanced Systemic Mastocytosis Showing Profound and Durable Clinical Activity
Blueprint Medicines Corporation (NASDAQ: BPMC), a leader in discovering and developing targeted kinase medicines for patients with genomically defined diseases, today announced updated data from its ongoing Phase 1...More >>
Blueprint Medicines Corporation (NASDAQ: BPMC), a leader in discovering and developing targeted kinase medicines for patients with genomically defined diseases, today announced updated data from its ongoing Phase 1...More >>
New DIN Rail Mounted EMI Filter Series from API Eases Installation and Enhances EMI Protection for Improved EMC Compliance
New DIN Rail Mounted EMI Filter Series from API Eases Installation and Enhances EMI Protection for Improved EMC Compliance
API Technologies Corp. (API), a leading provider of high performance RF and microwave signal conditioning and electromagnetic spectrum management solutions, announced its new series of DIN Rail Mounted EMI Filters for...More >>
API Technologies Corp. (API), a leading provider of high performance RF and microwave signal conditioning and electromagnetic spectrum management solutions, announced its new series of DIN Rail Mounted EMI Filters for...More >>
CenTrak Reports Significant Growth in Hand Hygiene Business and an Increase in Hospital Compliance Rates
CenTrak Reports Significant Growth in Hand Hygiene Business and an Increase in Hospital Compliance Rates
CenTrak, the market leader in Enterprise Location and Sensing Services™ and KLAS Category leader for Real Time Location Systems (RTLS), has deployed it's hand hygiene compliance solution in over fifty of its nearly one...More >>
CenTrak, the market leader in Enterprise Location and Sensing Services™ and KLAS Category leader for Real Time Location Systems (RTLS), has deployed it's hand hygiene compliance solution in over fifty of its nearly one...More >>
LeapFrog Investments: Goodlife Pharmacy, East Africa’s Leading Pharmacy Brand Named ‘Portfolio Company of the Year’ at the 2018 Private Equity Africa GP & Advisor Awards
LeapFrog Investments: Goodlife Pharmacy, East Africa’s Leading Pharmacy Brand Named ‘Portfolio Company of the Year’ at the 2018 Private Equity Africa GP & Advisor Awards
Company is on target to rise to address the health needs of 5.5 million emerging consumers Goodlife Pharmacy, designated 'Portfolio Company of the Year' at the Private Equity Africa GP & Advisor Awards 2018One...More >>
Company is on target to rise to address the health needs of 5.5 million emerging consumers Goodlife Pharmacy, designated 'Portfolio Company of the Year' at the Private Equity Africa GP & Advisor Awards 2018One...More >>
Dr. Steven Morris Leverages Decades of Surgical Experience to Become Specialist Marketing Consultant
Dr. Steven Morris Leverages Decades of Surgical Experience to Become Specialist Marketing Consultant
With a long and illustrious background in the cosmetic surgery industry, his new role as a specialist marketing consultant will see Dr. Steven Morris deliver expert marketing guidance to others in the field. As a highly...More >>
With a long and illustrious background in the cosmetic surgery industry, his new role as a specialist marketing consultant will see Dr. Steven Morris deliver expert marketing guidance to others in the field. As a highly...More >>
AbbVie Announces New Undetectable Minimal Residual Disease Data from Phase 3 Relapsed/Refractory Chronic Lymphocytic Leukemia MURANO Trial of Venetoclax in Combination with Rituximab at 23rd European Hematology Association Annual Congress
AbbVie Announces New Undetectable Minimal Residual Disease Data from Phase 3 Relapsed/Refractory Chronic Lymphocytic Leukemia MURANO Trial of Venetoclax in Combination with Rituximab at 23rd European Hematology Association Annual Congress
AbbVie (NYSE: ABBV), a research-based global biopharmaceutical company, today announced the presentation of investigational data from a new analysis of undetectable minimal residual disease (uMRD) rates from the pivotal...More >>
AbbVie (NYSE: ABBV), a research-based global biopharmaceutical company, today announced the presentation of investigational data from a new analysis of undetectable minimal residual disease (uMRD) rates from the pivotal...More >>
European Hematology Association: Update on bb2121, a Promising Therapy for Patients with Heavily Pre-treated Relapsed/Refractory Multiple Myeloma
European Hematology Association: Update on bb2121, a Promising Therapy for Patients with Heavily Pre-treated Relapsed/Refractory Multiple Myeloma
The anti-BCMA CAR T cell therapy bb2121 has demonstrated substantial activity in heavily pre-treated patients with multiple myeloma (MM). Updated results from 43 patients after five more months of follow-up show that...More >>
The anti-BCMA CAR T cell therapy bb2121 has demonstrated substantial activity in heavily pre-treated patients with multiple myeloma (MM). Updated results from 43 patients after five more months of follow-up show that...More >>
Kyros Law is Investigating Claims on Behalf of Invokana users: 1,100 Invokana Lawsuits Alleging Diabetic Ketoacidosis, Kidney Injury, Amputations and Heart Complications Filed.
Kyros Law is Investigating Claims on Behalf of Invokana users: 1,100 Invokana Lawsuits Alleging Diabetic Ketoacidosis, Kidney Injury, Amputations and Heart Complications Filed.
Kyros Law Offices is alerting individuals that have suffered serious side effects from taking Invokana that it is investigating filing legal claims seeking compensation for their injuries. According to a February 22nd...More >>
Kyros Law Offices is alerting individuals that have suffered serious side effects from taking Invokana that it is investigating filing legal claims seeking compensation for their injuries. According to a February 22nd...More >>
North America Pulse Oximeter Market Report 2018
North America Pulse Oximeter Market Report 2018
The "North America Pulse Oximeter Market Analysis (2017-2023)" report has been added to ResearchAndMarkets.com's offering. The North America Pulse Oximeter Market is expected to witness market growth of 5.9% CAGR...More >>
The "North America Pulse Oximeter Market Analysis (2017-2023)" report has been added to ResearchAndMarkets.com's offering. The North America Pulse Oximeter Market is expected to witness market growth of 5.9% CAGR...More >>
Overwhelming Success of First International NASH Day Paves Way for a Promising Edition In 2019
Overwhelming Success of First International NASH Day Paves Way for a Promising Edition In 2019
Following the great success of the First International NASH Day held on June 12, 2018, which has ignited enormous global enthusiasm beyond its 25 host cities and online, The NASH Education Program™ announces that: A second...More >>
Following the great success of the First International NASH Day held on June 12, 2018, which has ignited enormous global enthusiasm beyond its 25 host cities and online, The NASH Education Program™ announces that: A second...More >>
Hanger Reports First Quarter 2018 Results
Hanger Reports First Quarter 2018 Results
Hanger, Inc. (OTC PINK: HNGR), a leading provider of orthotic and prosthetic patient care services and solutions, today announced the filing of its Quarterly Report on Form 10-Q for the three months ended March 31, 2018...More >>
Hanger, Inc. (OTC PINK: HNGR), a leading provider of orthotic and prosthetic patient care services and solutions, today announced the filing of its Quarterly Report on Form 10-Q for the three months ended March 31, 2018...More >>
Genomma Lab Announces Acquisition of Bufferin®, Cheracol D® and Rose Milk® Brands - Expands OTC Offerings in the U.S.
Genomma Lab Announces Acquisition of Bufferin®, Cheracol D® and Rose Milk® Brands - Expands OTC Offerings in the U.S.
Genomma Lab Internacional, S.A.B. de C.V. (BMV: LABB) ("Genomma Lab" or "the Company"), one of the leading pharmaceutical and personal care products companies in Mexico with an increasing international presence, today...More >>
Genomma Lab Internacional, S.A.B. de C.V. (BMV: LABB) ("Genomma Lab" or "the Company"), one of the leading pharmaceutical and personal care products companies in Mexico with an increasing international presence, today...More >>
Livongo for Diabetes Improves Health of People with Type 2 Diabetes, New Study Finds
Livongo for Diabetes Improves Health of People with Type 2 Diabetes, New Study Finds
Use of Livongo for Diabetes significantly improves the health of people with type 2 diabetes (T2D), according to a new study published in the Journal of Diabetes Research. Researchers also found pairing participation in...More >>
Use of Livongo for Diabetes significantly improves the health of people with type 2 diabetes (T2D), according to a new study published in the Journal of Diabetes Research. Researchers also found pairing participation in...More >>
Altru® Health System Improves Patient Care with Expanded Use of Cutting-Edge Sterilization Technology
Altru® Health System Improves Patient Care with Expanded Use of Cutting-Edge Sterilization Technology
Duodenoscopes now sterilized with low-temperature sterilizerMore >>
Duodenoscopes now sterilized with low-temperature sterilizerMore >>
CUBEX LLC introduces CUBEX Mini, a revolutionary device for storage and management of controlled substances in veterinary medicine
CUBEX LLC introduces CUBEX Mini, a revolutionary device for storage and management of controlled substances in veterinary medicine
CUBEX LLC, the leading provider of pharmacy and supply management technology to the animal health market, announced the introduction CUBEX® Mini, a solution for veterinarians looking to reduce the legal and financial risks...More >>
CUBEX LLC, the leading provider of pharmacy and supply management technology to the animal health market, announced the introduction CUBEX® Mini, a solution for veterinarians looking to reduce the legal and financial risks...More >>
Taiho Oncology and Servier to Present Data on LONSURF® (trifluridine and tipiracil) and Key Investigational Compound TAS-120 at ESMO 20th World Congress on Gastrointestinal Cancer 2018
Taiho Oncology and Servier to Present Data on LONSURF® (trifluridine and tipiracil) and Key Investigational Compound TAS-120 at ESMO 20th World Congress on Gastrointestinal Cancer 2018
Taiho Oncology, Inc. and Servier today announced that clinical data for LONSURF® (trifluridine and tipiracil, TAS-102) are being presented at the ESMO 20th World Congress on Gastrointestinal Cancer 2018 (ESMO-GI) in...More >>
Taiho Oncology, Inc. and Servier today announced that clinical data for LONSURF® (trifluridine and tipiracil, TAS-102) are being presented at the ESMO 20th World Congress on Gastrointestinal Cancer 2018 (ESMO-GI) in...More >>
Global Table-top Spirometer Market 2018-2022
Global Table-top Spirometer Market 2018-2022
About Table-top Spirometer A table-top spirometer is a medical apparatus that is used to measure the volume of air inhaled and exhaled by the lungs. The device produces a spirogram that is a graphic record of the...More >>
About Table-top Spirometer A table-top spirometer is a medical apparatus that is used to measure the volume of air inhaled and exhaled by the lungs. The device produces a spirogram that is a graphic record of the...More >>
Global CAR T Cell Therapy Market 2016-2026: The Most Hot Topic Discussed Among Oncologists Throughout the Globe
Global CAR T Cell Therapy Market 2016-2026: The Most Hot Topic Discussed Among Oncologists Throughout the Globe
The "Global CAR T Cell Therapy Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2018 To 2026" report has been added to...More >>
The "Global CAR T Cell Therapy Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2018 To 2026" report has been added to...More >>
Global Medical Bionics Market, 2018-2026: Analysis & Forecast by Heart, Orthopedic, Ear, Vision & Neural Bionics
Global Medical Bionics Market, 2018-2026: Analysis & Forecast by Heart, Orthopedic, Ear, Vision & Neural Bionics
The "Global Medical Bionics Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2018 To 2026" report has been added to...More >>
The "Global Medical Bionics Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2018 To 2026" report has been added to...More >>
CONCIERGE KEY Health Enhances Member Services And Expands Access With Android Launch
CONCIERGE KEY Health Enhances Member Services And Expands Access With Android Launch
CONCIERGE KEY Health™-a concierge health service that offers on-demand access to top-tier doctor specialists-is pleased to announce its expanded availability to Android operating systems and unveil its sleek, optimized...More >>
CONCIERGE KEY Health™-a concierge health service that offers on-demand access to top-tier doctor specialists-is pleased to announce its expanded availability to Android operating systems and unveil its sleek, optimized...More >>
BlueWind Medical Receives FDA Approval for Pivotal Trial Design of RENOVA iStim™ Implantable Tibial Nerve Neuromodulator for Overactive Bladder
BlueWind Medical Receives FDA Approval for Pivotal Trial Design of RENOVA iStim™ Implantable Tibial Nerve Neuromodulator for Overactive Bladder
HERZLIYA, Israel, June 14, 2018 /CNW/ - BlueWind Medical, a developer of a miniature wireless neurostimulation platform, for the treatment of multiple clinical indications, announced today that the US Food and Drug...More >>
BlueWind Medical, a developer of a miniature wireless neurostimulation platform, for the treatment of multiple clinical indications, announced today that the US Food and Drug Administration (FDA) has approved the...More >>
Global Cancer Therapeutics Market Expected to Reach $178,863 Million by 2023
Global Cancer Therapeutics Market Expected to Reach $178,863 Million by 2023
According to a new report published by Allied Market Research, titled, "Cancer Therapeutics Market by Application and End User: Global Opportunity Analysis and Industry Forecast, 2017-2023", the market was valued at...More >>
According to a new report published by Allied Market Research, titled, "Cancer Therapeutics Market by Application and End User: Global Opportunity Analysis and Industry Forecast, 2017-2023", the market was valued at...More >>
Global CNS Therapeutics Market 2018-2022: Increased Adoption of New-Generation Drugs
Global CNS Therapeutics Market 2018-2022: Increased Adoption of New-Generation Drugs
The "Global CNS Therapeutics Market 2018-2022" report has been added to ResearchAndMarkets.com's offering. The Global CNS therapeutics market to grow at a CAGR of 4.36% during the period 2018-2022. Global CNS...More >>
The "Global CNS Therapeutics Market 2018-2022" report has been added to ResearchAndMarkets.com's offering. The Global CNS therapeutics market to grow at a CAGR of 4.36% during the period 2018-2022. Global CNS...More >>
Tranquinatur, a product by Spanish company El Naturalista, helps reduce anxiety and promotes relaxation
Tranquinatur, a product by Spanish company El Naturalista, helps reduce anxiety and promotes relaxation
El Naturalista, a company with more than 50 years of experience producing health and wellness supplements, offers an extended variety of natural products obtained through non-synthetic procedures ensuring a lower number of...More >>
El Naturalista, a company with more than 50 years of experience producing health and wellness supplements, offers an extended variety of natural products obtained through non-synthetic procedures ensuring a lower number of...More >>
Global Bariatric Surgery Devices Market, 2018-2026 - Market is Expected to Reach US$ 3,163.5 Million
Global Bariatric Surgery Devices Market, 2018-2026 - Market is Expected to Reach US$ 3,163.5 Million
The "Global Bariatric Surgery Devices Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2018 To 2026" report has been added to...More >>
The "Global Bariatric Surgery Devices Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2018 To 2026" report has been added to...More >>
U.S. FDA Approves Moxidectin For The Treatment Of River Blindness
U.S. FDA Approves Moxidectin For The Treatment Of River Blindness
Medicines Development for Global Health (MDGH) and the World Health Organisation Special Programme for Research and Training in Tropical Diseases (TDR) announced today that the United States (U.S.) Food and Drug...More >>
Medicines Development for Global Health (MDGH) and the World Health Organisation Special Programme for Research and Training in Tropical Diseases (TDR) announced today that the United States (U.S.) Food and Drug...More >>
Crescita Therapeutics™ Announces Director Election Results of its Annual General Meeting
Crescita Therapeutics™ Announces Director Election Results of its Annual General Meeting
LAVAL, QC, June 13, 2018 /PRNewswire/ - Crescita Therapeutics Inc. (TSX: CTX) (Crescita or the Company), a commercial dermatology company with a portfolio of non-prescription skincare and prescription drug products for the...More >>
LAVAL, QC, June 13, 2018 /PRNewswire/ - Crescita Therapeutics Inc. (TSX: CTX) (Crescita or the Company), a commercial dermatology company with a portfolio of non-prescription skincare and prescription drug products for the...More >>
Intabio to Collaborate with Bruker on Novel Interface For Bruker's UHR-QTOF Mass Spectrometers
Intabio to Collaborate with Bruker on Novel Interface For Bruker's UHR-QTOF Mass Spectrometers
Intabio, Inc., announced today that it has entered into a collaboration with Bruker to accelerate integration of Intabio's Blaze™ solution with Bruker's high resolution mass spectrometers (MS). Intabio's Blaze™...More >>
Intabio, Inc., announced today that it has entered into a collaboration with Bruker to accelerate integration of Intabio's Blaze™ solution with Bruker's high resolution mass spectrometers (MS). Intabio's Blaze™...More >>
Nisin Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018 - 2026
Nisin Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018 - 2026
Transparency Market Research offer 8-year forecast for the global nisin market between 2018 and 2026. The global nisin market is expected to register a CAGR of 4.2% during the forecast period. The primary objective of the...More >>
Transparency Market Research offer 8-year forecast for the global nisin market between 2018 and 2026. The global nisin market is expected to register a CAGR of 4.2% during the forecast period. The primary objective of the...More >>
RegeneRx Holds Annual Meeting
RegeneRx Holds Annual Meeting
RegeneRx Biopharmaceuticals, Inc. (OTCQB: RGRX) ("the Company" or "RegeneRx"), today held its 2018 Annual Meeting. Seventy-eight of the Company's stockholders voted on four proposals. Each proposal was approved by a...More >>
RegeneRx Biopharmaceuticals, Inc. (OTCQB: RGRX) ("the Company" or "RegeneRx"), today held its 2018 Annual Meeting. Seventy-eight of the Company's stockholders voted on four proposals. Each proposal was approved by a...More >>
Isothermal Bags & Containers Market - Global Industry, Size, Share, Growth, Trends and Forecast 2018 - 2026
Isothermal Bags & Containers Market - Global Industry, Size, Share, Growth, Trends and Forecast 2018 - 2026
Transparency Market Research examines the global isothermal bags & containers market during the forecast period 2018-2026.The primary objective of the report is to identify opportunities in the market and present...More >>
Transparency Market Research examines the global isothermal bags & containers market during the forecast period 2018-2026.The primary objective of the report is to identify opportunities in the market and present...More >>
Infusion Pumps Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018 - 2026
Infusion Pumps Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018 - 2026
Global Infusion Pumps Market: Overview Infusion pumps are used to deliver therapeutic drugs and fluids such as plasma, dextrose, and saline solutions into a patient's body at a precise and controlled rate.These devices...More >>
Global Infusion Pumps Market: Overview Infusion pumps are used to deliver therapeutic drugs and fluids such as plasma, dextrose, and saline solutions into a patient's body at a precise and controlled rate.These devices...More >>
Depression Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018 - 2026
Depression Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018 - 2026
Depression Drugs Market - Overview This report analyzes the global depression drugs market in terms of its current and future scenario. Increase in prevalence of major depression disorders, rise in government initiatives...More >>
Depression Drugs Market - Overview This report analyzes the global depression drugs market in terms of its current and future scenario. Increase in prevalence of major depression disorders, rise in government initiatives...More >>
AMO Pharma Receives FDA Orphan Drug Designation for AMO-04 in Treatment of Rett Syndrome
AMO Pharma Receives FDA Orphan Drug Designation for AMO-04 in Treatment of Rett Syndrome
AMO Pharma Limited ("AMO Pharma"), a privately held biopharmaceutical company focusing on rare, debilitating diseases with limited or no treatment options, announced today that the U.S. Food and Drug Administration has...More >>
AMO Pharma Limited ("AMO Pharma"), a privately held biopharmaceutical company focusing on rare, debilitating diseases with limited or no treatment options, announced today that the U.S. Food and Drug Administration has...More >>
Liquidweb: 2.5 Million Euro to the Italian Innovative SME which has Developed BrainControl, a Brain-computer Interface Based Device that Allows Locked-in Patients to Communicate via Brainwaves
Liquidweb: 2.5 Million Euro to the Italian Innovative SME which has Developed BrainControl, a Brain-computer Interface Based Device that Allows Locked-in Patients to Communicate via Brainwaves
RedSeed Ventures financially supports the innovative SME with 2.5 million Euro. New partners are joining Pasquale Fedele, the inventor of BrainControl, who gained a total of 2.5 million Euro in a round of funding led by...More >>
RedSeed Ventures financially supports the innovative SME with 2.5 million Euro. New partners are joining Pasquale Fedele, the inventor of BrainControl, who gained a total of 2.5 million Euro in a round of funding led by...More >>
Positive Histopathology Data from Pilot Study Adds to Growing Body of Evidence Supporting the Utility of Ortho-R in Rotator Cuff Repair
Positive Histopathology Data from Pilot Study Adds to Growing Body of Evidence Supporting the Utility of Ortho-R in Rotator Cuff Repair
KIRKLAND, QC, June 13, 2018 /CNW/ - Ortho Regenerative Technologies Inc. (CSE: ORTH) ("Ortho RTi" or the "Corporation") an emerging Orthopaedic and Sports Medicine Technology company, today announced positive outcomes data...More >>
KIRKLAND, QC, June 13, 2018 /CNW/ - Ortho Regenerative Technologies Inc. (CSE: ORTH) ("Ortho RTi" or the "Corporation") an emerging Orthopaedic and Sports Medicine Technology company, today announced positive outcomes data...More >>
Alcami's Extended Workbench Supports Commercial Supply of Flexion Therapeutics's ZILRETTA® (triamcinolone acetonide extended-release injectable suspension)
Alcami's Extended Workbench Supports Commercial Supply of Flexion Therapeutics's ZILRETTA® (triamcinolone acetonide extended-release injectable suspension)
Alcami Corporation, a leading provider of fully-integrated custom end-to-end solutions for the pharmaceutical and biotechnology industries, today announced the expanded deployment of its Extended Workbench laboratory...More >>
Alcami Corporation, a leading provider of fully-integrated custom end-to-end solutions for the pharmaceutical and biotechnology industries, today announced the expanded deployment of its Extended Workbench laboratory...More >>
Cerapedics Receives 2018 MedTech Breakthrough Award for Best New Surgical Technology Solution
Cerapedics Receives 2018 MedTech Breakthrough Award for Best New Surgical Technology Solution
Cerapedics, a privately-held orthobiologics company, today announced that it has been selected as a winner in the 2018 MedTech Breakthrough Awards program. The award recognizes the company's i-FACTOR™ Peptide Enhanced...More >>
Cerapedics, a privately-held orthobiologics company, today announced that it has been selected as a winner in the 2018 MedTech Breakthrough Awards program. The award recognizes the company's i-FACTOR™ Peptide Enhanced...More >>
Global Urinary Incontinence Devices Market to 2023: Market Size is Expected to Reach $3.6 Billion
Global Urinary Incontinence Devices Market to 2023: Market Size is Expected to Reach $3.6 Billion
The "Global Urinary Incontinence Devices Market Analysis (2017-2023)" report has been added to ResearchAndMarkets.com's offering. The Global Urinary Incontinence Devices Market size is expected to reach $3.6 billion...More >>
The "Global Urinary Incontinence Devices Market Analysis (2017-2023)" report has been added to ResearchAndMarkets.com's offering. The Global Urinary Incontinence Devices Market size is expected to reach $3.6 billion...More >>
Quebecers Living with Advanced Parkinson's Disease Now Have Broader Access to NEUPRO® (rotigotine) As Add-On Therapy
Quebecers Living with Advanced Parkinson's Disease Now Have Broader Access to NEUPRO® (rotigotine) As Add-On Therapy
OAKVILLE, ON, June 13, 2018 /CNW/ - UCB Canada Inc. announced today that Quebecers now have publicly funded access (special authorization) to NEUPRO® (rotigotine) for the treatment of advanced stage Parkinson's Disease...More >>
OAKVILLE, ON, June 13, 2018 /CNW/ - UCB Canada Inc. announced today that Quebecers now have publicly funded access (special authorization) to NEUPRO® (rotigotine) for the treatment of advanced stage Parkinson's Disease...More >>
Elbit Systems' Surgeon-Centered Visualization Spin-Off, Beyeonics, Raises $11.5 Million
Elbit Systems' Surgeon-Centered Visualization Spin-Off, Beyeonics, Raises $11.5 Million
Elbit Systems Ltd. (NASDAQ: ESLT) (TASE: ESLT) ("Elbit Systems") announced today that it's subsidiary, Beyeonics Surgical Ltd. ("Beyeonics"), concluded a first round of funding raising a $11.5 million investment from...More >>
Elbit Systems Ltd. (NASDAQ: ESLT) (TASE: ESLT) ("Elbit Systems") announced today that it's subsidiary, Beyeonics Surgical Ltd. ("Beyeonics"), concluded a first round of funding raising a $11.5 million investment from...More >>
CRH Medical Corporation Announces Voting Results of its 2018 Annual General Meeting of Shareholders
CRH Medical Corporation Announces Voting Results of its 2018 Annual General Meeting of Shareholders
VANCOUVER, June 12, 2018 /PRNewswire/ - CRH Medical Corporation (the "Company") (TSX: CRH) (NYSE MKT: CRHM), announced the following voting results for the Company's 2018 Annual Meeting of Shareholders held today (the...More >>
VANCOUVER, June 12, 2018 /PRNewswire/ - CRH Medical Corporation (the "Company") (TSX: CRH) (NYSE MKT: CRHM), announced the following voting results for the Company's 2018 Annual Meeting of Shareholders held today (the...More >>
REGENXBIO Receives FDA Fast Track Designation for RGX-111 Gene Therapy for the Treatment of Mucopolysaccharidosis Type I
REGENXBIO Receives FDA Fast Track Designation for RGX-111 Gene Therapy for the Treatment of Mucopolysaccharidosis Type I
REGENXBIO Inc. (Nasdaq: RGNX), a leading clinical-stage biotechnology company seeking to improve lives through the curative potential of gene therapy based on its proprietary NAV® Technology Platform, today announced that...More >>
REGENXBIO Inc. (Nasdaq: RGNX), a leading clinical-stage biotechnology company seeking to improve lives through the curative potential of gene therapy based on its proprietary NAV® Technology Platform, today announced that...More >>
Ascletis Receives NDA Approval from China FDA for Ganovo
Ascletis Receives NDA Approval from China FDA for Ganovo
Ascletis announced today that China Food and Drug Administration (CFDA) has approved its Category 1 new drug, Ganovo (also known as Danoprevir or ASC08), for the treatment of viral hepatitis C. Ganovo is the first...More >>
Ascletis announced today that China Food and Drug Administration (CFDA) has approved its Category 1 new drug, Ganovo (also known as Danoprevir or ASC08), for the treatment of viral hepatitis C. Ganovo is the first...More >>
Regenerative Medicine Market, 2022
Regenerative Medicine Market, 2022
The "Global Regenerative Medicine Market Analysis & Forecast to 2022; Stem Cells, Tissue Engineering, BioBanking & CAR-T Industries" report has been added to ResearchAndMarkets.com's offering. This report...More >>
The "Global Regenerative Medicine Market Analysis & Forecast to 2022; Stem Cells, Tissue Engineering, BioBanking & CAR-T Industries" report has been added to ResearchAndMarkets.com's offering. This report...More >>
OxThera Announces the Appointment of Dr Alain Munoz to its Board of Directors
OxThera Announces the Appointment of Dr Alain Munoz to its Board of Directors
OxThera AB, a Stockholm-based privately-held biopharmaceutical company with a product in late stage clinical development focusing on Primary hyperoxaluria (PH), announces the appointment of Dr Alain Munoz to its board...More >>
OxThera AB, a Stockholm-based privately-held biopharmaceutical company with a product in late stage clinical development focusing on Primary hyperoxaluria (PH), announces the appointment of Dr Alain Munoz to its board...More >>
Statement from FDA Commissioner Scott Gottlieb, M.D., on new agency efforts to advance the patient voice in medical product development and FDA regulatory decision-making
Statement from FDA Commissioner Scott Gottlieb, M.D., on new agency efforts to advance the patient voice in medical product development and FDA regulatory decision-making
Over the past decade, advances in our understanding of the basic biology of serious and life-threatening diseases has led to the development and FDA approval of targeted treatments for patients with a specific molecular...More >>
Over the past decade, advances in our understanding of the basic biology of serious and life-threatening diseases has led to the development and FDA approval of targeted treatments for patients with a specific molecular...More >>
Better Care and Shorter Wait Times for Montefiore Patients
Better Care and Shorter Wait Times for Montefiore Patients
Bronx and Westchester residents are more satisfied with their primary care visits, and are waiting less time to see their doctors than ever before. The accolades are tied to a new designation from the National Committee on...More >>
Bronx and Westchester residents are more satisfied with their primary care visits, and are waiting less time to see their doctors than ever before. The accolades are tied to a new designation from the National Committee on...More >>
Vascular Patches Market Worth 525.8 Million USD by 2023
Vascular Patches Market Worth 525.8 Million USD by 2023
According to a new market research report "Vascular Patches Market by Material (Biologic, Synthetic), Application (Carotid Endarterectomy, Open Repair of Abdominal Aortic Aneurysms, Vascular Bypass Surgery), Patient Care...More >>
According to a new market research report "Vascular Patches Market by Material (Biologic, Synthetic), Application (Carotid Endarterectomy, Open Repair of Abdominal Aortic Aneurysms, Vascular Bypass Surgery), Patient Care...More >>
Viral Vectors and Plasmid DNA Manufacturing Market (2nd Edition), 2018-2030
Viral Vectors and Plasmid DNA Manufacturing Market (2nd Edition), 2018-2030
INTRODUCTION Genetically modified therapies have emerged as a promising treatment option for various diseases (primarily ones that currently have no cure), including cancers, inherited disorders and certain viral...More >>
INTRODUCTION Genetically modified therapies have emerged as a promising treatment option for various diseases (primarily ones that currently have no cure), including cancers, inherited disorders and certain viral...More >>
The U.S. surgical microscopes market size is expected to reach USD 385.2 million by 2025
The U.S. surgical microscopes market size is expected to reach USD 385.2 million by 2025
U.S. Surgical Microscopes Market Size, Share & Trends Analysis Report By Type (On Casters, Ceiling Mounted, Wall Mounted), By Application, By End-use (Hospital, Physician's/Dentists Clinic), And Segment Forecasts,...More >>
U.S. Surgical Microscopes Market Size, Share & Trends Analysis Report By Type (On Casters, Ceiling Mounted, Wall Mounted), By Application, By End-use (Hospital, Physician's/Dentists Clinic), And Segment Forecasts,...More >>
HOY HEALTH Launches HoyMEDS Prescription Savings Program
HOY HEALTH Launches HoyMEDS Prescription Savings Program
Hoy Health LLC, an innovative health-tech start-up that offers access to quality healthcare programs through state-of-the-art technology, announced today the launch of a new prescription savings program, HoyMEDS, in a...More >>
Hoy Health LLC, an innovative health-tech start-up that offers access to quality healthcare programs through state-of-the-art technology, announced today the launch of a new prescription savings program, HoyMEDS, in a...More >>
The global procedure trays market size is expected to reach USD 18.9 billion by 2025
The global procedure trays market size is expected to reach USD 18.9 billion by 2025
Procedure Trays Market Size, Share & Trends Analysis Report By Product (Operating Room, Angiography, Ophthalmology), By End-Use (Hospitals, Clinics), By Region, Vendor Landscape, And Segment Forecasts, 2018 - 2025 ...More >>
Procedure Trays Market Size, Share & Trends Analysis Report By Product (Operating Room, Angiography, Ophthalmology), By End-Use (Hospitals, Clinics), By Region, Vendor Landscape, And Segment Forecasts, 2018 - 2025 ...More >>
Innovit Helps Medical Devices Manufacturers Meet Regulatory Compliance, Reduce Counterfeiting with UDI Multi-Connector Product
Innovit Helps Medical Devices Manufacturers Meet Regulatory Compliance, Reduce Counterfeiting with UDI Multi-Connector Product
Innovit, a global master data management solution provider, today announced the availability of its Unique Device Identification (UDI) Multi-Connector solution, which helps medical device manufacturers keep pace with...More >>
Innovit, a global master data management solution provider, today announced the availability of its Unique Device Identification (UDI) Multi-Connector solution, which helps medical device manufacturers keep pace with...More >>
Galmed's 600 mg Aramchol™ Achieved a Regulatory Approvable Endpoint Showing NASH Resolution Without Worsening of Fibrosis, in NASH Patients, in the Global Phase 2b ARREST 52-Week Study
Galmed's 600 mg Aramchol™ Achieved a Regulatory Approvable Endpoint Showing NASH Resolution Without Worsening of Fibrosis, in NASH Patients, in the Global Phase 2b ARREST 52-Week Study
Statistically significant reduction in liver fat was demonstrated by Magnetic Resonance Spectroscopy (MRS) in patients completing 52 weeks of treatment with Aramchol 400mg vs. placebo. Post hoc analysis of MRS responders,...More >>
Statistically significant reduction in liver fat was demonstrated by Magnetic Resonance Spectroscopy (MRS) in patients completing 52 weeks of treatment with Aramchol 400mg vs. placebo. Post hoc analysis of MRS responders,...More >>
ProMIS Neurosciences Initiates Manufacturing of PMN310, its Lead Therapeutic Antibody for Treatment of Alzheimer's Disease
ProMIS Neurosciences Initiates Manufacturing of PMN310, its Lead Therapeutic Antibody for Treatment of Alzheimer's Disease
Program is on track for clinical trial start in H2 2019More >>
Program is on track for clinical trial start in H2 2019More >>
Grünenthal Initiates Pivotal Phase III Trials in Complex Regional Pain Syndrome
Grünenthal Initiates Pivotal Phase III Trials in Complex Regional Pain Syndrome
Grünenthal announced today that first patients have been enrolled in two trials of the company's pivotal phase III program investigating neridronate for the treatment of Complex Regional Pain Syndrome (CRPS). These two...More >>
Grünenthal announced today that first patients have been enrolled in two trials of the company's pivotal phase III program investigating neridronate for the treatment of Complex Regional Pain Syndrome (CRPS). These two...More >>
Biosimulation Market Size Worth $3.77 Billion By 2024 | CAGR 15.4%: Grand View Research, Inc.
Biosimulation Market Size Worth $3.77 Billion By 2024 | CAGR 15.4%: Grand View Research, Inc.
The global biosimulation market size is expected to reach USD 3.77 billion by 2024, according to a new report by Grand View Research, Inc., registering a CAGR of 15.4% during the forecast period. Soaring need for advanced...More >>
The global biosimulation market size is expected to reach USD 3.77 billion by 2024, according to a new report by Grand View Research, Inc., registering a CAGR of 15.4% during the forecast period. Soaring need for advanced...More >>
Global Medical Ceramics (Bioresorbable, Bioinert, Bioactive) Market 2018-2024
Global Medical Ceramics (Bioresorbable, Bioinert, Bioactive) Market 2018-2024
The "Medical Ceramics Market: Global Industry Analysis, Trends, Market Size and Forecasts up to 2024" report has been added to ResearchAndMarkets.com's offering. The report predicts the global medical ceramics market...More >>
The "Medical Ceramics Market: Global Industry Analysis, Trends, Market Size and Forecasts up to 2024" report has been added to ResearchAndMarkets.com's offering. The report predicts the global medical ceramics market...More >>
Global Gastric Cancer Drugs Market 2016-2018 & 2024 by Route of Administration, Lines of Chemotherapy & Molecule Type
Global Gastric Cancer Drugs Market 2016-2018 & 2024 by Route of Administration, Lines of Chemotherapy & Molecule Type
The "Gastric Cancer Drugs Market: Global Industry Analysis, Trends, Market Size and Forecasts up to 2024" report has been added to ResearchAndMarkets.com's offering. The report predicts the global gastric cancer...More >>
The "Gastric Cancer Drugs Market: Global Industry Analysis, Trends, Market Size and Forecasts up to 2024" report has been added to ResearchAndMarkets.com's offering. The report predicts the global gastric cancer...More >>
Global Immunoglobulin Products Market 2018-2024: Market to Grow with a CAGR of 8.5%
Global Immunoglobulin Products Market 2018-2024: Market to Grow with a CAGR of 8.5%
The "Immunoglobulin Products Market: Global Industry Analysis, Trends, Market Size and Forecasts up to 2024" report has been added to ResearchAndMarkets.com's offering. The report predicts the global immunoglobulin...More >>
The "Immunoglobulin Products Market: Global Industry Analysis, Trends, Market Size and Forecasts up to 2024" report has been added to ResearchAndMarkets.com's offering. The report predicts the global immunoglobulin...More >>
GLOBAL OTC PHARMACEUTICAL MARKET FORECAST 2018-2028
GLOBAL OTC PHARMACEUTICAL MARKET FORECAST 2018-2028
Forecasts by Product (Cough, Cold and Allergy, Analgesics, Gastrointestinal, Dermatology, Eye Care, Smoking Cessation Aids, Others) and Geography, with Analysis of Leading Companies Read the full report:...More >>
Forecasts by Product (Cough, Cold and Allergy, Analgesics, Gastrointestinal, Dermatology, Eye Care, Smoking Cessation Aids, Others) and Geography, with Analysis of Leading Companies Read the full report:...More >>
CHECKPOINT INHIBITORS FOR TREATING CANCER MARKET REPORT 2018-2028
CHECKPOINT INHIBITORS FOR TREATING CANCER MARKET REPORT 2018-2028
Analysing Prospects for PD-1 Inhibitors, CLTA-4 Inhibitors and Pipeline Drugs Read the full report: https://www.reportlinker.com/p05222504 Report Details Checkpoint Inhibitors for Treating Cancer ' our new study...More >>
Analysing Prospects for PD-1 Inhibitors, CLTA-4 Inhibitors and Pipeline Drugs Read the full report: https://www.reportlinker.com/p05222504 Report Details Checkpoint Inhibitors for Treating Cancer ' our new study...More >>
GLOBAL MELANOMA DRUGS MARKET 2018-2028
GLOBAL MELANOMA DRUGS MARKET 2018-2028
By Kinase Inhibitors, by Immunotherapeutic Agents, by Chemotherapeutic Agents, Tafinlar, Mekinist, Zelbroaf, Yervoy, Proleukin, Keytruda, PegIntron, Roferon-A, Dacarbazine, Temodar/Temodal and Leading Companies Read the...More >>
By Kinase Inhibitors, by Immunotherapeutic Agents, by Chemotherapeutic Agents, Tafinlar, Mekinist, Zelbroaf, Yervoy, Proleukin, Keytruda, PegIntron, Roferon-A, Dacarbazine, Temodar/Temodal and Leading Companies Read the...More >>
The sterilization equipment market is expected to reach USD 11.14 billion by 2023 from USD 7.94 billion in 2018, at a CAGR of 7.0%
The sterilization equipment market is expected to reach USD 11.14 billion by 2023 from USD 7.94 billion in 2018, at a CAGR of 7.0%
The global sterilization equipment market projected to grow at a CAGR of 7.0% during the forecast period. Read the full report: https://www.reportlinker.com/p03176844 The sterilization equipment market is expected to...More >>
The global sterilization equipment market projected to grow at a CAGR of 7.0% during the forecast period. Read the full report: https://www.reportlinker.com/p03176844 The sterilization equipment market is expected to...More >>
United States Laboratory Medical Supply Utilization Trends Report, Q3 2017: Index Shifts for Hospital Labs are Due to Higher Reporting in Test Volumes
United States Laboratory Medical Supply Utilization Trends Report, Q3 2017: Index Shifts for Hospital Labs are Due to Higher Reporting in Test Volumes
The "Q3 Laboratory 2017: Medical Supply Utilization Trends" report has been added to ResearchAndMarkets.com's offering The laboratory test-volume-weighted utilization index shows slight expansion in Q3 2017 for both...More >>
The "Q3 Laboratory 2017: Medical Supply Utilization Trends" report has been added to ResearchAndMarkets.com's offering The laboratory test-volume-weighted utilization index shows slight expansion in Q3 2017 for both...More >>
The generic drugs market is estimated at $257.3bn in 2017
The generic drugs market is estimated at $257.3bn in 2017
Growth in Leading Regional and National Markets ' North America, Europe, Asia-Pacific, Middle-East & Africa, Latin America, US, Canada, Germany, France, UK, Italy, Spain, India, China, Australia, South Korea,...More >>
Growth in Leading Regional and National Markets ' North America, Europe, Asia-Pacific, Middle-East & Africa, Latin America, US, Canada, Germany, France, UK, Italy, Spain, India, China, Australia, South Korea,...More >>
Global Ocular Cancer Drug Development Pipeline Review 2018: 35 Products in Active Development Featuring Novartis and Eli Lilly
Global Ocular Cancer Drug Development Pipeline Review 2018: 35 Products in Active Development Featuring Novartis and Eli Lilly
The "Ocular Cancer Drug Development Pipeline Review, 2018" report has been added to ResearchAndMarkets.com's offering. Ocular Cancer Drug Development Pipeline Review, 2018 provides an overview of the pipeline...More >>
The "Ocular Cancer Drug Development Pipeline Review, 2018" report has been added to ResearchAndMarkets.com's offering. Ocular Cancer Drug Development Pipeline Review, 2018 provides an overview of the pipeline...More >>
Inflammatory Skin Diseases Drug Development Pipeline Review, 2018: 17 Products in Development Featuring GlaxoSmithKline and Novartis
Inflammatory Skin Diseases Drug Development Pipeline Review, 2018: 17 Products in Development Featuring GlaxoSmithKline and Novartis
The "Inflammatory Skin Diseases Drug Development Pipeline Review, 2018" report has been added to ResearchAndMarkets.com's offering. There are 17 products in development for this indication, and companies operating in...More >>
The "Inflammatory Skin Diseases Drug Development Pipeline Review, 2018" report has been added to ResearchAndMarkets.com's offering. There are 17 products in development for this indication, and companies operating in...More >>
United States Extended Care Medical Supply Utilization Trends Report, Q3-2017 - Index Value Increased by 1.9 Points to 26.8
United States Extended Care Medical Supply Utilization Trends Report, Q3-2017 - Index Value Increased by 1.9 Points to 26.8
The "Q3 Extended Care 2017: Medical Supply Utilization Trends" report has been added to ResearchAndMarkets.com's offering. The Extended Care Acuity-Weighted index shows slight to moderate expansion in Q3 2017. The...More >>
The "Q3 Extended Care 2017: Medical Supply Utilization Trends" report has been added to ResearchAndMarkets.com's offering. The Extended Care Acuity-Weighted index shows slight to moderate expansion in Q3 2017. The...More >>
United States Physician Office Medical Supply Utilization Trends, Q4 2017
United States Physician Office Medical Supply Utilization Trends, Q4 2017
The "Q4 Physician Office 2017: Medical Supply Utilization Trends" report has been added to ResearchAndMarkets.com's offering. Physician market growth picked up and continues slight expansion, with the national index...More >>
The "Q4 Physician Office 2017: Medical Supply Utilization Trends" report has been added to ResearchAndMarkets.com's offering. Physician market growth picked up and continues slight expansion, with the national index...More >>
Global X-ray Security Scanner Market 2018-2025: Health Concerns Related To X-Ray Radiations Hampering The Growth Of Full-Body X-Ray Scanners
Global X-ray Security Scanner Market 2018-2025: Health Concerns Related To X-Ray Radiations Hampering The Growth Of Full-Body X-Ray Scanners
The "X-ray Security Scanner Market to 2025 - Global Analysis and Forecasts by Product Type (Body Scanner and Baggage Scanner), and End-user (Air Transport, Land Security, Commercial Malls & Multiplexes, Government...More >>
The "X-ray Security Scanner Market to 2025 - Global Analysis and Forecasts by Product Type (Body Scanner and Baggage Scanner), and End-user (Air Transport, Land Security, Commercial Malls & Multiplexes, Government...More >>
Creatinine Measurement Market Worth 564.5 Million USD by 2023
Creatinine Measurement Market Worth 564.5 Million USD by 2023
According to a new market research report "Creatinine Measurement Market by Product (Kits, Reagents), Test Type (Jaffe method, Enzymatic creatinine method), Sample (Serum Creatinine, Urine) and End User (Hospitals,...More >>
According to a new market research report "Creatinine Measurement Market by Product (Kits, Reagents), Test Type (Jaffe method, Enzymatic creatinine method), Sample (Serum Creatinine, Urine) and End User (Hospitals,...More >>
Biobanking Market Forecasts 2018-2028 - Visiongain Report
Biobanking Market Forecasts 2018-2028 - Visiongain Report
Discover Prospects for Medical Research and Therapeutic Uses, Including Human Tissues, Stem Cells (Adult Stem Cells, Umbilical Cord), Other applications (DNA, RNA, body fluids), Leading Biobanking Companies and Key...More >>
Discover Prospects for Medical Research and Therapeutic Uses, Including Human Tissues, Stem Cells (Adult Stem Cells, Umbilical Cord), Other applications (DNA, RNA, body fluids), Leading Biobanking Companies and Key...More >>
Pii Announces Positive Inspection News from FDA and MHRA
Pii Announces Positive Inspection News from FDA and MHRA
Pharmaceutics International, Inc. (Pii), a Contract Development Manufacturing Organization (CDMO) based in Hunt Valley, Maryland, received notification on June 4, 2018 from the Medicines and Health Care products Regulatory...More >>
Pharmaceutics International, Inc. (Pii), a Contract Development Manufacturing Organization (CDMO) based in Hunt Valley, Maryland, received notification on June 4, 2018 from the Medicines and Health Care products Regulatory...More >>
FDA Approves Addition Of Positive Overall Survival Data From Phase 3 ASPIRE Trial To KYPROLIS® (carfilzomib) Label
FDA Approves Addition Of Positive Overall Survival Data From Phase 3 ASPIRE Trial To KYPROLIS® (carfilzomib) Label
Amgen (NASDAQ:AMGN) today announced that the U.S. Food and Drug Administration (FDA) has approved the supplemental New Drug Application (sNDA) to add the positive overall survival (OS) data from the Phase 3 ASPIRE trial to...More >>
Amgen (NASDAQ:AMGN) today announced that the U.S. Food and Drug Administration (FDA) has approved the supplemental New Drug Application (sNDA) to add the positive overall survival (OS) data from the Phase 3 ASPIRE trial to...More >>
SCYNEXIS Presents SCY-078 Data at ASM Microbe 2018
SCYNEXIS Presents SCY-078 Data at ASM Microbe 2018
SCYNEXIS, Inc. (NASDAQ:SCYX), a biotechnology company developing innovative therapies for difficult-to-treat and often life-threatening infections, today announced the presentation of data at American Society for...More >>
SCYNEXIS, Inc. (NASDAQ:SCYX), a biotechnology company developing innovative therapies for difficult-to-treat and often life-threatening infections, today announced the presentation of data at American Society for...More >>
Global Regenerative Medicine Market Expected to Reach $39,325 Million by 2023, Says Allied Market Research
Global Regenerative Medicine Market Expected to Reach $39,325 Million by 2023, Says Allied Market Research
According to a new report published by Allied Market Research, titled, Regenerative Medicine Market by Product Type, Material, and Application: Global Opportunity Analysis and Industry Forecast, 2017-2023," the global...More >>
According to a new report published by Allied Market Research, titled, Regenerative Medicine Market by Product Type, Material, and Application: Global Opportunity Analysis and Industry Forecast, 2017-2023," the global...More >>
Correvio Provides U.S. Regulatory Update for BRINAVESS
Correvio Provides U.S. Regulatory Update for BRINAVESS
NASDAQ: CORV TSX: CORVMore >>
NASDAQ: CORV TSX: CORVMore >>

PR Newswire IndexMore>>
Entertainment News Releases via PRNewswire
Entertainment
Entertainment News Releases via PRNewswire
Travel
Travel News Releases via PRNewswire
Political Campaigns
Political Campaigns News Releases via PRNewswire
Medicine & Pharmaceuticals
Medicine & Pharmaceuticals News Releases via PRNewswire
Film & Motion Picture News Releases via PRNewswire
Film & Motion Picture
Film & Motion Picture News Releases via PRNewswire
Economic News and Analysis
Economic News Releases via PRNewswire
Computer Software
Computer Software News Releases via PRNewswire
Computer Networks
Computer Networks News Releases via PRNewswire
Computer Hardware
Computer Hardware News Releases via PRNewswire
Biotech News Releases via PRNewswire
Biotechnology
Biotechnology News Releases via PRNewswire

ABC6 ExtraMore>>
Contests
Contests
Contests
Click here to see our ABC6 Contests page!
More >>
Click here to see our ABC6 Contests page!
More >>
Lottery
Lottery
Is today your lucky day? Click here to get the daily numbers.More >>
Horoscopes
Horoscopes
Daily horoscopes for life, love, work and more!More >>
Green Living
Green Living
Find latest environmental news, tips and information for staying green.More >>
Pets
Pets
Learn more tips for caring for, grooming and training your favorite pet.More >>

Medicine & Pharmaceuticals - ABC6 - Providence, RI and New Bedford, MA News, Weather

HeadlinesMore>>